Overgrowth of gut yeast in newborns may increase asthma risk
An overgrowth of yeast in the gut within the first few months of life may cause changes to the immune […]
DUBLIN–(BUSINESS WIRE)–Dec. 27, 2018– Horizon Pharma plc (NASDAQ: HZNP) today announced the U.S. Food and Drug Administration (FDA) has approved […] A novel diagnostic approach using epigenetic immune monitoring to screen newborns for inherited diseases could expand the number of life-threatening […]newborns
Horizon Pharma plc Announces FDA Approval to Expand the Age Range for Ravicti (glycerol phenylbutyrate) Oral Liquid to Include Newborns
Epigenetic immune cell diagnostic tool helps detect diseases in newborns not currently identified